Patents for A61K 49 - Preparations for testing in vivo (35,376)
04/2004
04/15/2004WO2003080554A3 Iodinated triglyceride analogs
04/15/2004WO2003075835A3 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
04/15/2004WO2003070752A3 Mhc-peptide complex binding ligands
04/15/2004WO2003039449A3 Modulation of dopaminergic neurons
04/15/2004WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/15/2004WO2003019142A3 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
04/15/2004US20040072875 Use of parathyroid hormone-related protein (PTHrP) in the diagnosis and treatment of chronic lung disease and other pathologies
04/15/2004US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents
04/15/2004US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses
04/15/2004US20040071762 Diagnostic test for schizophrenia, using niacin
04/15/2004US20040071709 Corona-virus-like particles comprising functionally deleted genomes
04/15/2004US20040071693 Humanised antibodies
04/15/2004US20040071689 Administering library then collecting and analyzing sample of biological target material
04/15/2004US20040071669 Transplants for myocardial scars
04/15/2004US20040071656 Modulation of heat-shock-protein-based immunotherapies
04/15/2004US20040071634 Mouse disease model for evaluation of prophylactic and therapeuthic treatments of chlamydia
04/15/2004US20040071632 Determining plaque location using human monoclonal antibody fragment cloned by phage display that binds specifically to oxidized forms of low density lipoproteins
04/15/2004US20040071631 Use of radiopharmaceuticals and intraoperative radiation probe for delivery of treatment materials
04/15/2004CA2500670A1 Ratios of collagen peptides, their uses and products
04/15/2004CA2499573A1 Method for convection enhanced delivery of therapeutic agents
04/14/2004EP1408118A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase
04/14/2004EP1406879A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP1406669A2 Conjugates of an antioxidants with metal chelating ligands
04/14/2004EP1406664A2 Targeting chemical compounds to cells
04/14/2004EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
04/14/2004EP1380295A9 Photosensitiser and method for production thereof
04/14/2004EP1163012A4 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms
04/14/2004EP1105399B1 Carboxylated phosphatidic acid esters
04/14/2004EP0525199B2 Composition containing ultrafine particles of magnetic metal oxide
04/14/2004CN1489478A Medicine preparations for diagnosing infection with helicobacter pyloni
04/13/2004US6720314 Use of a vital dye for facilitating surgical procedures for cataract extraction
04/13/2004US6720145 Classification of preferential dermatitus; obtain skin sample, recover nucleotide sequences, monitor expression pattern of cytokine, classify dermatitis
04/13/2004US6719958 Polychelants, their complexes with metal ions, their preparation and their uses
04/08/2004WO2004029080A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
04/08/2004WO2004028569A1 Polymer compositions for administration to animals
04/08/2004WO2004028551A1 Novel agents that modulate eph receptor activity
04/08/2004WO2004028449A2 Azulene dimer-quenched, near-infrared fluorescent probes
04/08/2004WO2004028338A2 A method to demonstrate the efficacy of pharmacological stress agent
04/08/2004WO2003101530A3 Solid hydrogel coupling for ultrasound imaging and therapy
04/08/2004WO2003089012A3 Cavity filling biopsy site marker
04/08/2004WO2003013616A8 Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics
04/08/2004WO2002087629A9 Ct scanner for imaging a preselected portion of a patient
04/08/2004WO2002087500A9 Viral enzyme activated prototoxophores and use of same to treat viral infections
04/08/2004WO2002083854A3 Antibodies to vla-1
04/08/2004US20040068177 Method for imaging an artery using a magnetic resonance contrast agent
04/08/2004US20040067886 Reducing pain; administering protein kinase c inhibitor; side effect reduction
04/08/2004US20040067540 Rapid method for screening compounds for in vivo activity
04/08/2004US20040067235 Methods for the use of neurotoxin in the treatment of urologic disorders
04/08/2004US20040067221 Cell delivery fluid for prevention of cell settling in delivery system
04/08/2004US20040067201 MRI image enhancement compositions
04/08/2004US20040067198 Emissive multichromophoric systems
04/08/2004US20040067196 Targeted therapeutic lipid constructs
04/08/2004CA2499580A1 Novel agents that modulate eph receptor activity
04/08/2004CA2498826A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
04/07/2004EP1405651A1 Evaluation or diagnostics kit
04/07/2004EP1404861A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
04/07/2004EP1404377A2 Improved chelator conjugates
04/07/2004EP1404375A1 Imaging infection using fluorescent protein as a marker
04/07/2004EP1404372A1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1
04/07/2004EP1404371A2 Peptide-based compounds for targeting intergin receptors
04/07/2004EP1404356A2 Cd10-activated prodrug compounds
04/07/2004EP1404293A1 Infection control system
04/07/2004EP0946525B1 Method for producing metal complex carboxylic acid amides
04/07/2004CN1487947A Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
04/06/2004US6717030 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm
04/06/2004US6716413 Indole compounds as tissue-specific exogenous optical agents
04/06/2004US6716412 Methods of ultrasound treatment using gas or gaseous precursor-filled compositions
04/06/2004US6716410 Using humanized monoclonal antibody (mab) or fragment with variable chain with oxidation specific epitopes
04/06/2004CA2168575C Use of photodynamic therapy to treat prostatic tissue
04/06/2004CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
04/01/2004WO2004027385A2 Engineering of material surfaces
04/01/2004WO2004026407A1 Use of inhibitors of compounds involved in the jun kinase (jnk) biochemical cellular pathway for the treatment or diagnosis of liposarcomas
04/01/2004WO2004026344A1 Bifunctional contrast agent comprising a fluorescent dye and an mri contrast agent
04/01/2004WO2004026282A1 Thermolabile liposome with a controlled release temperature
04/01/2004WO2004026249A2 Methods and compositions for preventing skin damage
04/01/2004WO2004026111A2 Flexible and/or elastic brachytherapy seed or strand
04/01/2004WO2004026100A2 Using magnetic resonance imaging to directly map neuronal activity
04/01/2004WO2004005889A3 Detection of drug-resistant human immunodeficiency virus
04/01/2004WO2003106498A3 Ox40 (=cd134) receptor agonistic and therapeutic use
04/01/2004WO2003106495A3 Humanized monoclonal antiboby hpam4
04/01/2004WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions
04/01/2004WO2003091694A3 Method for assay of cognition and memory based on low frequency stimulation
04/01/2004WO2003088913A3 Peptide deformylase activated prodrugs
04/01/2004WO2003086474A3 Fluorinated or paramagnetic alginate polymer, annexin paramagnetic conjugate, and their use as contrasting agent in mri
04/01/2004WO2003075742A3 Biomarker for efficacy of appetite suppressant drugs
04/01/2004WO2003066021A3 Drug nanoparticles with lysozyme surface stabiliser
04/01/2004WO2003009842A8 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
04/01/2004US20040063735 Calcitonin gene related peptide receptor antagonists
04/01/2004US20040062796 Enteric administering; anticancer, antiulcer agents; drug with bioadhesive ligand
04/01/2004US20040062778 Surface dissolution and/or bulk erosion controlled release compositions and devices
04/01/2004US20040062715 Macromolecule biosensor; magnetic resonance signals
04/01/2004US20040062712 Methods of screening agents for activity using teleosts
04/01/2004US20040060569 Surface topography method for determining effect of a botulinum toxin upon a muscle
03/2004
03/31/2004EP1402268A2 Chemical capture reagent
03/31/2004EP1402264A1 Assay for beta cell toxic macrolides
03/31/2004EP1402066A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
03/31/2004EP1402033A2 Novel endothelially expressed dnas and proteins, and their use
03/31/2004EP1402000A2 Structural and cytoskeleton-associated proteins
03/31/2004EP1401818A2 Targeted multivalent macromolecules